Heparin anticoagulation during cardiopulmonary bypass in an antithrombin-III deficient patient. Implications relative to the etiology of heparin rebound.
暂无分享,去创建一个
[1] C. Kisker,et al. Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomer. , 1978, The Annals of thoracic surgery.
[2] B. Bull,et al. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. , 1975, The Journal of thoracic and cardiovascular surgery.
[3] B. Bull,et al. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols. , 1975, The Journal of thoracic and cardiovascular surgery.
[4] J. Cranley. Letter: Dosage errors with heparin. , 1975, JAMA.
[5] D. Thomas. Therapeutic role of heparin in acute pulmonary embolism. , 1975, Current therapeutic research, clinical and experimental.